Trial Dates Expected for PPI Lawsuits

Introduction

On October 11, 2017, Federal Court summoned for a Status Conference for Nexium, Prilosec, and Prevacid Lawsuits. Trial dates are expected soon for this group of proton-pump inhibitors which have 275 lawsuits pending in the multidistrict litigation in the U.S. District Court, District of New Jersey. The main allegation faced by the manufacturers: AstraZeneca Pharmaceuticals LP, Procter & Gamble Co., McKesson Corp., Takeda Pharmaceuticals USA Inc., Novartis Pharmaceuticals Corp., Pfizer Inc., and Pfizer subsidiary Wyeth is that their products caused kidney injuries including acute interstitial nephritis (AIN), chronic kidney disease, and end-stage renal disease.

Comments

Supreme Court Upholds Flavored Vape Ban

Categories: E-Cigarette: JUUL

The U.S. Supreme Court has unanimously upheld a decision by the Food and Drug Administration (FDA) to block the sale and marketing of certain flavored e-cigarette products.

The ruling supports the FDA’s authority to regulate tobacco…

Judge Rejects JnJ's $10B Talc Lawsuit Settlement

Categories: Talcum

Johnson & Johnson's shares fell more than 5% after a U.S. bankruptcy judge rejected its $10 billion settlement proposal aimed at resolving over 60,000 lawsuits.

These lawsuits allege that the company’s…

Tepezza Hearing Loss MDL: Bellwether Trials Set for 2026

Categories: Tepezza

A U.S. District Judge overseeing Tepezza hearing damage lawsuits nationwide has scheduled four bellwether trials for 2026. These trials are intended to help both parties assess how juries may respond to the evidence and testimonies that could be…

Trial Dates Expected for PPI Lawsuits